Abrams Cancer Center of the University of Pennsylvania

Philadelphia, Pennsylvania 19104

0 studies enrolling now · 6 studies all time

What they study most

Glioblastoma, Glioma, Malignant, Gliosarcoma, High Grade Glioma (III or IV), Lymphopenia, MGMT-Unmethylated Glioblastoma, Malignant Glioma, Recurrent Brain Neoplasm, Recurrent Glioblastoma

Studies at this site

• GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas — Completed
• Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma — Stopped early
• Terameprocol in Treating Patients With Recurrent High Grade Glioma — Completed
• Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18) — Completed
• Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas — Stopped early
• HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma — Completed